iBio (IBIO) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
iBio, Inc. (IBIO) demonstrates stability regardless of market volatility, relying on internal product development milestones. This price action visualization on GURU.Markets shows EV/EBITDA at 0.00. iBio, Inc. (IBIO) utilizes neural networks for protein engineering, accelerating the transition to oncology trials. Its success is driven by the quality of AI-driven antibody design and the potential to license technologies to market behemoths.
ibioinc.com - analytical breakdowns and key metrics (IBIO)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
IBIO - Net Financial Result|Expected Profit iBio, Inc.|IBIO - Market Cap to Earnings|Projected Price to Earnings iBio, Inc.|IBIO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple iBio Corporation|IBIO - Operating income before deduction of amortization|Earnings per share for the last twelve months iBio|IBIO - Earnings per share for the last 12 months|Quarterly EPS earnings growth ibioinc.com|IBIO - Net earnings per share growth this year|Expected earnings per share growth for next year iBio, Inc.
Initial company analysis:iBio Corp IBIO
iBio, Inc. is minimizing biological risks through the diversification of anti-tumor drug development and the implementation of AI-driven antibody screening. An analysis of the company's EV/EBITDA dynamics allows for a real-time assessment of the total enterprise value, including net debt relative to operating profit, where the consolidation on the chart serves as a signal of position accumulation by major players ahead of a potential impulsive price movement.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|PHVS: EV/EBITDA Multiple|ABCL (AbCellera) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Precigen Inc (PGEN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|NKTR - Company Value to EBITDA|Upstream Bio Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ZBIO|Immunome - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Gossamer Bio Inc GOSS|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation SEPN|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio savarapharma.com (SVRA)|Enterprise Value to EBITDA Ratio RIGL (Rigel Pharmaceuticals, Inc.)|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc|EV/EBITDA Multiple ATXS (Astria Pharma)|Total Company Value to Operating Income Before Depreciation Ratio enGene Corp (ENGN)|RAPT Therapeutics - EV/EBITDA Multiple|JBIO: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACRS: EV/EBITDA Multiple|KYTX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tiziana Life Sciences PLC|Company Value to EBITDA Cabaletta Bio Inc CABA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ventyx Biosciences (VTYX)|THTX: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|Business Value to Operating Income Before Depreciation ELDN|Agenus Inc - EV/EBITDA Multiple|CLYM - EV/EBITDA Multiple|Zura Bio (ZURA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|atyrpharma.com - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adagene Inc|Enterprise Value to EBITDA Ratio Ikena Oncology, Inc. (IMA)|EV/EBITDA Multiple STTK|EV/EBITDA Multiple equilliumbio.com (EQ)|Connect Biopharma Holdings Limited - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IMUX|Atara Biotherapeutics Inc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio InflaRx N.V. IFRX|X4 Pharma (XFOR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Adicet Bio, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|Enterprise Value to EBITDA Ratio inmunebio.com (INMB)|Enterprise Value to EBITDA Ratio BRNS (Barinthus Biotherapeutics plc)|EV/EBITDA Multiple Kezar Life Sciences Inc. (KZR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics, Inc SABS|AKTX: Enterprise Value to Operating Income Before Depreciation|Enlivex Therapeutics, Ltd. - EV/EBITDA Multiple|Company Value to EBITDA Q32 Bio Inc.|GOVX: EV/EBITDA Multiple|EDSA - Total Company Value to Operating Income Before Depreciation Ratio|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization XTLB|EV/EBITDA Multiple BOLT|Total Company Value to Operating Income Before Depreciation Ratio hcwbiologics.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|aimimmuno.com (AIM) - Company Value to EBITDA|ADTX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GRI (GRI Bio Corporation)|XRTX: EV/EBITDA Multiple|HIND - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to Operating Income Before Depreciation INDP (Indaptus Therapeutics Inc)|EV/EBITDA Multiple SCNI|Enterprise Value to EBITDA Ratio calcimedica.com CALI|Affimed N.V. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Allakos Inc (ALLK)|HOOKIPA - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|ITOS: EV/EBITDA Multiple|OCEA (Ocean Biomedical Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
